摘要
目的:分析和探讨紫杉醇在抗肿瘤应用中的不良反应及临床用药效果。方法:选取70例于2016年12月至2017年12月在我院治疗的肿瘤患者,对其使用紫杉醇药物进行治疗,1个月之后,统计患者发生不良反应的种类以及数量及不良反应发生概率。结果:患者使用抗肿瘤药物紫杉醇出现的不良反应类型分别为骨髓抑制、过敏反应、消化系统、手足麻木以及肝脏损伤,不良反应发生率分别为5.71%、14.29%、2.86%、4.29%和7.14%。结论:紫杉醇在治疗肿瘤的过程中,虽不良反应发生率较低,但也要充分考虑可能出现的不良反应,给予必要的预防及治疗。
Objective:To analyze and discuss the adverse reactions of paclitaxel in antineoplastic application and its clinical efficacy. Methods: 70 cases of tumor treated in our hospital from December 2016 to December 2017 were treated with paclitaxel. A month later, the type, number and probability of adverse reactions were counted. Results: The types of adverse reactions of paclitaxel were bone marrow suppression, allergic reaction, digestive system, numbness of hands and feet, and liver injury. The incidence of adverse reactions were 5.71%, 14.29%, 2.86%, 4.29% and 7.14%, respectively. Conclusion:Although the incidence of adverse reactions of paclitaxel in the treatment of tumors is low, it is necessary to take full account of the possible adverse reactions and give necessary prevention and treatment.
作者
张鹤
Zhang He(Pharmaceutical Department, Second Hospital of Fushun City, Liaoning Province, 113000)
出处
《中国药物滥用防治杂志》
CAS
2019年第3期153-155,共3页
Chinese Journal of Drug Abuse Prevention and Treatment
关键词
抗肿瘤药
紫杉醇
不良反应
antineoplastic drugs
paclitaxel
adverse reactions
